Inspira Technologies OXY B.H.N. Ltd. has received notification of 510(k) class II clearance from the U.S. Food and Drug Administration (FDA) for its INSPIRA ART100, a Cardiopulmonary Bypass System. Dagi Ben Noon, CEO of Inspira, said “This is a proud moment for...
READ MORE




